HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ABBISKO-B

13.180

+0.3302.57%

Volume:552.00K

Turnover:7.19M

Market Cap:8.86B

PE:291.03

High:13.200

Open:13.010

Low:12.750

Close:12.850

52wk High:19.780

52wk Low:4.930

Shares:672.00M

HK Float Shares:672.00M

Volume Ratio:0.97

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.045

ROE:6.88%

ROA:2.27%

PB:3.52

PE(LYR):291.03

PS:12.64

Loading ...

Overview Company News Filings

Abbisko Cayman (2256) Schedules Board Meeting to Approve 2025 Annual Results

Bulletin Express

Abbisko Cayman Board to Approve Audited Annual Results and Consider Final Dividend

Abbisko Unit Doses First U.S. Patient in Phase 1 Study of Liver Cancer Drug

MT Newswires Live

Abbisko Cayman Limited (2256) Announces First U.S. Patient Dosing in Global Phase I Irpagratinib Trial

Bulletin Express

Abbisko Therapeutics Doses First U.S. Patient in Global Phase I Study of Irpagratinib

BRIEF-Abbisko Cayman Says FDA Grants Fast Track Designation To Abbisko's Irpagratinib

Abbisko Cayman (2256) Subsidiary Gains FDA Fast Track for FGFR4 Inhibitor in HCC

Bulletin Express

ABBISKO-B's FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation for Liver Cancer Treatment

Abbisko-Tochter Abbisko Therapeutics erhält FDA Fast Track Designation für HCC-Medikament

Abbisko Cayman Ltd - FDA Grants Fast Track Designation to Abbisko's Irpagratinib

THOMSON REUTERS

Abbisko Cayman (02256) Announces Monthly Return for January 2026

Bulletin Express

Assessing Abbisko Cayman (SEHK:2256) Valuation After FDA Acceptance Of Pimicotinib NDA

Simply Wall St.

Zhongtai Securities Maintains "Buy" Rating on ABBISKO-B (02256), Notes Progress of ABSK021 Towards Approval in China and US

BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDA

Abbisko Tumor Treatment Pimicotinib Accepted for U.S. Review

MT Newswires Live

ABBISKO-B (02256) Announces FDA Acceptance of Bejema® NDA for TGCT Treatment

Abbisko Cayman - Unit's New Drug Application for Colony-Stimulating Factor 1 Receptor Inhibitor Pimicotinib Formally Accepted by US FDA

THOMSON REUTERS

Abbisko Therapeutics Secures FDA Acceptance for Pimicotinib NDA

Major Breakthrough: Abbisko-B's (02256) Tenosynovial Giant Cell Tumor Drug Bejema® NDA Accepted by FDA

FDA Accepts Abbisko Cayman NDA for Pimicotinib in Tenosynovial Giant Cell Tumor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02256/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"ABBISKO-B","latestPrice":13.18,"timestamp":1771214886002,"preClose":12.85,"halted":0,"volume":552000,"delay":0,"changeRate":0.025680933852140084,"floatShares":672000000,"shares":672000000,"eps":0.04528702352132157,"marketStatus":"Closed The third day of Lunar New Year","change":0.33,"latestTime":"02-16 12:08:06","open":13.01,"high":13.2,"low":12.75,"amount":7187530,"amplitude":0.035019,"askPrice":13.19,"askSize":2000,"bidPrice":13.18,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":0.25213727818456033,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":7,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":12.85,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":0.9708079705244339,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":672000000,"roa":"2.27%","roe":"6.88%","lyrEps":0.045287,"volumeRatio":0.9708079705244339,"shares":672000000,"dividePrice":0,"high":13.2,"amplitude":0.035019,"preClose":12.85,"low":12.75,"week52Low":4.93,"pbRate":"3.52","psRate":"12.64","week52High":19.78,"institutionHeld":0,"latestPrice":13.18,"committee":0.6,"eps":0.04528702352132157,"divideRate":0,"volume":552000,"delay":0,"ttmEps":0.25213727818456033,"open":13.01,"prevYearClose":13.01,"prevWeekClose":12.85,"prevMonthClose":12.5,"prevQuarterClose":13.01,"fiveDayClose":12.93,"twentyDayClose":14.07,"sixtyDayClose":13.6,"earningDate":1772380800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2026-03-02","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772415000000,"name":null,"time":"","dateTimestamp":1772380800000,"actualEps":null},{"date":"2025-08-04","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754271000000,"name":null,"time":"","dateTimestamp":1754236800000,"actualEps":null},{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"Post Market","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"Post Market","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1762272000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2026-02-16","current":52.257602,"percent":0.794776,"low":-234.512257,"twenty":-5.08831,"median":-1.515445,"eighty":53.455609,"high":254.727882,"avg":4.380019,"sd":82.527287,"marketCap":8861722593},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796},{"date":"2025-04-25","current":157.525338,"twenty":-7.035077,"median":-3.06483,"eighty":-1.297429,"marketCap":4745757129},{"date":"2025-05-02","current":164.646937,"twenty":-6.98082,"median":-3.059687,"eighty":-1.294598,"marketCap":4970852329},{"date":"2025-05-09","current":160.887021,"twenty":-6.966007,"median":-3.058035,"eighty":-1.289956,"marketCap":4891435796},{"date":"2025-05-16","current":166.920406,"twenty":-6.956944,"median":-3.054843,"eighty":-1.284736,"marketCap":5116329396},{"date":"2025-05-23","current":172.811396,"twenty":-6.918805,"median":-3.051744,"eighty":-1.280509,"marketCap":5312740129},{"date":"2025-05-30","current":194.14447,"twenty":-6.859825,"median":-3.047185,"eighty":-1.269715,"marketCap":5994823373},{"date":"2025-06-06","current":193.852557,"twenty":-6.827912,"median":-3.029734,"eighty":-1.263923,"marketCap":6001081017},{"date":"2025-06-13","current":206.909864,"twenty":-6.817054,"median":-3.027014,"eighty":-1.258681,"marketCap":6407827906},{"date":"2025-06-20","current":226.129725,"twenty":-6.80981,"median":-3.021411,"eighty":-1.253542,"marketCap":6989324733},{"date":"2025-06-27","current":219.382855,"twenty":-6.774951,"median":-3.010594,"eighty":-1.249178,"marketCap":6799778035},{"date":"2025-07-04","current":207.131321,"twenty":-6.751721,"median":-3.004715,"eighty":-1.245928,"marketCap":6420343195},{"date":"2025-07-11","current":194.227376,"twenty":-6.748553,"median":-2.997106,"eighty":-1.23779,"marketCap":6014301773},{"date":"2025-07-18","current":239.206864,"twenty":-6.742193,"median":-2.992401,"eighty":-1.233081,"marketCap":7401298850},{"date":"2025-07-25","current":223.606361,"twenty":-6.733962,"median":-2.987644,"eighty":-1.227416,"marketCap":6943764012},{"date":"2025-08-01","current":221.508288,"twenty":-6.720681,"median":-2.97652,"eighty":-1.21075,"marketCap":6836108756},{"date":"2025-08-08","current":50.470458,"twenty":-6.69485,"median":-2.968177,"eighty":-1.205206,"marketCap":8274964605},{"date":"2025-08-15","current":65.75115,"twenty":-6.664055,"median":-2.960553,"eighty":-1.200737,"marketCap":10764181600},{"date":"2025-08-22","current":69.328024,"twenty":-6.623327,"median":-2.952385,"eighty":-1.196881,"marketCap":11314163907},{"date":"2025-08-29","current":70.197956,"twenty":-6.58783,"median":-2.944688,"eighty":-1.195394,"marketCap":11510826312},{"date":"2025-09-05","current":74.741403,"twenty":-6.545813,"median":-2.931892,"eighty":-1.193197,"marketCap":12243700183},{"date":"2025-09-12","current":74.279336,"twenty":-6.493001,"median":-2.918097,"eighty":-1.190811,"marketCap":12189911275},{"date":"2025-09-19","current":71.544121,"twenty":-6.455769,"median":-2.873353,"eighty":-1.179252,"marketCap":11732705557},{"date":"2025-09-26","current":69.674923,"twenty":-6.40006,"median":-2.852194,"eighty":-1.166431,"marketCap":11396524882},{"date":"2025-10-03","current":74.307,"twenty":-6.312512,"median":-2.838066,"eighty":-1.159178,"marketCap":12183187662},{"date":"2025-10-10","current":70.431829,"twenty":-6.288573,"median":-2.801814,"eighty":-1.154706,"marketCap":11530997152},{"date":"2025-10-17","current":63.17088,"twenty":-6.157723,"median":-2.769702,"eighty":-1.141961,"marketCap":10334193949},{"date":"2025-10-24","current":58.25878,"twenty":-5.928147,"median":-2.735891,"eighty":-1.138284,"marketCap":9534083943},{"date":"2025-10-31","current":59.730926,"twenty":-5.921366,"median":-2.711752,"eighty":-1.135193,"marketCap":9789581256},{"date":"2025-11-07","current":58.126276,"twenty":-5.917138,"median":-2.68435,"eighty":-1.120838,"marketCap":9520636716},{"date":"2025-11-14","current":60.172448,"twenty":-5.914987,"median":-2.645577,"eighty":-1.113983,"marketCap":9883711845},{"date":"2025-11-21","current":53.525201,"twenty":-5.81235,"median":-2.567515,"eighty":-1.103539,"marketCap":8787762844},{"date":"2025-11-28","current":58.350437,"twenty":-5.778066,"median":-2.550052,"eighty":-1.098391,"marketCap":9614767305},{"date":"2025-12-05","current":57.842944,"twenty":-5.775395,"median":-2.509912,"eighty":-1.092946,"marketCap":9547531170},{"date":"2025-12-12","current":58.224062,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"marketCap":9628214532},{"date":"2025-12-19","current":54.679817,"twenty":-5.762384,"median":-1.913119,"eighty":-1.074189,"marketCap":9063430998},{"date":"2025-12-24","current":54.10565,"twenty":-5.686352,"median":-1.597844,"eighty":-1.065407,"marketCap":8996194863},{"date":"2026-01-02","current":52.443492,"twenty":-5.575606,"median":-1.569456,"eighty":-1.038831,"marketCap":8754144777},{"date":"2026-01-09","current":57.857956,"twenty":-5.571211,"median":-1.54358,"eighty":49.652014,"marketCap":9682003440},{"date":"2026-01-16","current":58.071036,"twenty":-5.564242,"median":-1.534833,"eighty":52.436859,"marketCap":9749239575},{"date":"2026-01-23","current":55.601293,"twenty":-5.468644,"median":-1.525941,"eighty":53.637621,"marketCap":9325651924},{"date":"2026-01-30","current":49.88128,"twenty":-5.183001,"median":-1.52299,"eighty":53.637621,"marketCap":8404516875},{"date":"2026-02-06","current":50.312337,"twenty":-5.136266,"median":-1.517963,"eighty":53.524919,"marketCap":8498647464},{"date":"2026-02-13","current":50.856111,"twenty":-5.107703,"median":-1.515573,"eighty":53.489701,"marketCap":8639843347},{"date":"2026-02-16","current":52.222849,"twenty":-5.08831,"median":-1.515445,"eighty":53.455609,"marketCap":8861722593}],"updateTime":1771506700677},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138963360","title":"Abbisko Cayman (2256) Schedules Board Meeting to Approve 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1138963360","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138963360?lang=en_us&edition=fundamental","pubTime":"2026-02-11 16:44","pubTimestamp":1770799454,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (Stock Code: 2256) has announced that its board of directors will convene on Monday, 2 March 2026. The primary agenda includes reviewing and approving the audited annual...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2610498402","title":"Abbisko Cayman Board to Approve Audited Annual Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2610498402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610498402?lang=en_us&edition=fundamental","pubTime":"2026-02-11 16:33","pubTimestamp":1770798837,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Ltd. has announced that its board of directors will hold a meeting on Monday, 2 March 2026. The meeting will focus on considering and approving the audited annual results of the company and its subsidiaries for the year ended 31 December 2025, as well as the publication of these results and the consideration of a final dividend recommendation. For more details, refer to the official announcement included in the document above.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 11, 2026, and is solely responsible for the information contained therei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL9VLFdP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","IE00BPRC5H50.USD","LU2778985437.USD","BK1161","LU2476274308.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2610603104","title":"Abbisko Unit Doses First U.S. Patient in Phase 1 Study of Liver Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2610603104","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610603104?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:20","pubTimestamp":1770772829,"startTime":"0","endTime":"0","summary":"Abbisko Cayman  subsidiary has dosed the first patient in the U.S. in the expansion phase of a global Phase 1 clinical study of its FGFR4 inhibitor irpagratinib, according to a Wednesday Hong Kong bourse filing.The multicenter trial is evaluating irpagratinib in patients with advanced hepatocellular carcinoma with FGF19 overexpression, according to the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK1161","LU2476274720.SGD","LU2778985437.USD","02256"],"gpt_icon":0},{"id":"1120317248","title":"Abbisko Cayman Limited (2256) Announces First U.S. Patient Dosing in Global Phase I Irpagratinib Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1120317248","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120317248?lang=en_us&edition=fundamental","pubTime":"2026-02-11 08:20","pubTimestamp":1770769247,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (the “Company”), together with subsidiary Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics”), reported the successful first U.S. patient dosing in the expansion segment of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2610622670","title":"Abbisko Therapeutics Doses First U.S. Patient in Global Phase I Study of Irpagratinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2610622670","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610622670?lang=en_us&edition=fundamental","pubTime":"2026-02-11 08:00","pubTimestamp":1770768051,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics Co., Ltd., a subsidiary of Abbisko Cayman Ltd., has announced the successful dosing of the first patient in the United States in the expansion part of a global, multicenter Phase I clinical study of irpagratinib , a highly selective small-molecule FGFR4 inhibitor for patients with FGF19 overexpression advanced hepatocellular carcinoma. Irpagratinib was previously granted Fast Track Designation by the U.S. FDA, supporting its accelerated global clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 11, 2026, and is solely res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL20ttQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","02256","LU2476274308.USD","IE00B5MMRT66.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2476274720.SGD"],"gpt_icon":0},{"id":"2610693927","title":"BRIEF-Abbisko Cayman Says FDA Grants Fast Track Designation To Abbisko's Irpagratinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693927","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610693927?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:26","pubTimestamp":1770686764,"startTime":"0","endTime":"0","summary":"BRIEF-Abbisko Cayman Says FDA Grants Fast Track Designation To Abbisko's IrpagratinibFeb 10 (Reuters) - Abbisko Cayman 2256.HK:FDA GRANTS FAST TRACK DESIGNATION TO ABBISKO'S IRPAGRATINIBFurther company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274308.USD","BK1161","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU2778985437.USD","IE00B5MMRT66.SGD","02256","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1144741814","title":"Abbisko Cayman (2256) Subsidiary Gains FDA Fast Track for FGFR4 Inhibitor in HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=1144741814","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144741814?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:21","pubTimestamp":1770682899,"startTime":"0","endTime":"0","summary":"On February 10, 2026, Abbisko Cayman Limited (2256) announced that its subsidiary, Abbisko Therapeutics, received Fast Track Designation from the U.S. FDA for irpagratinib (ABSK-011), a highly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"1150857594","title":"ABBISKO-B's FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation for Liver Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1150857594","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150857594?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:08","pubTimestamp":1770682104,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its self-developed highly selective small-molecule FGFR4 inhibitor Irpagratinib...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","LU2476274720.SGD","IE00BPRC5H50.USD","LU2778985437.USD","BK1161","LU2476274308.USD","HCC","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2488822045.USD","BK4006"],"gpt_icon":0},{"id":"2610667611","title":"Abbisko-Tochter Abbisko Therapeutics erhält FDA Fast Track Designation für HCC-Medikament","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667611","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667611?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681650,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLLHXgF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU2476274720.SGD","02256","BK1161","IE00B5MMRT66.SGD","LU2488822045.USD","IE00B543WZ88.USD","LU2476274308.USD","LU2778985437.USD"],"gpt_icon":0},{"id":"2610066768","title":"Abbisko Cayman Ltd - FDA Grants Fast Track Designation to Abbisko's Irpagratinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2610066768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610066768?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681640,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02256","LU2488822045.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU2476274308.USD","BK1161","IE00B5MMRT66.SGD","LU2476274720.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1136358190","title":"Abbisko Cayman (02256) Announces Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136358190","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136358190?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:59","pubTimestamp":1770281966,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited (stock code: 02256) published its Monthly Return for the period ended 31 January 2026, indicating that the authorized share capital remains at 5,000,000,000 ordinary shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2605469153","title":"Assessing Abbisko Cayman (SEHK:2256) Valuation After FDA Acceptance Of Pimicotinib NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2605469153","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605469153?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:58","pubTimestamp":1769057928,"startTime":"0","endTime":"0","summary":"Abbisko Cayman (SEHK:2256) is back in focus after the U.S. FDA formally accepted the New Drug Application for pimicotinib, its oral CSF-1R inhibitor for tenosynovial giant cell tumor, following positive Phase III MANEUVER trial results.\nSee our latest analysis for Abbisko Cayman.\nInvestors appear to be weighing the FDA’s NDA acceptance against earlier gains, with a 1-month share price return of 7.85% and year to date share price return of 9.68%, while the 1-year total shareholder return is...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/assessing-abbisko-cayman-sehk2256-valuation-after-fda-accept","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2256/abbisko-cayman-shares/news/assessing-abbisko-cayman-sehk2256-valuation-after-fda-accept","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B543WZ88.USD","02256","LU2476274308.USD","IE00B5MMRT66.SGD","DCF","LU2778985437.USD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2476274720.SGD"],"gpt_icon":0},{"id":"1131784055","title":"Zhongtai Securities Maintains \"Buy\" Rating on ABBISKO-B (02256), Notes Progress of ABSK021 Towards Approval in China and US","url":"https://stock-news.laohu8.com/highlight/detail?id=1131784055","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131784055?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:00","pubTimestamp":1768528835,"startTime":"0","endTime":"0","summary":"Zhongtai Securities has issued a research report maintaining a \"Buy\" rating on ABBISKO-B (02256). The company's core pharmaceutical product, ABSK021, recently received approval for marketing from the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","BK1161","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","BK0276","02256","LU2488822045.USD","600918"],"gpt_icon":0},{"id":"2603507783","title":"BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603507783","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603507783?lang=en_us&edition=fundamental","pubTime":"2026-01-13 18:09","pubTimestamp":1768298971,"startTime":"0","endTime":"0","summary":"BRIEF-Abbisko Cayman's New Drug Application For Pimicotinib Formally Accepted By U.S. FDAJan 13  - Abbisko Cayman Ltd 2256.HK:UNIT'S NEW DRUG APPLICATION FOR COLONY-STIMULATING FACTOR 1 RECEPTOR INHIBITOR PIMICOTINIB FORMALLY ACCEPTED BY US FDAFurther company coverage: 2256.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU2488822045.USD","02256","LU2476274308.USD","IE00BPRC5H50.USD","LU2476274720.SGD","IE00B543WZ88.USD","BK1161","LU2778985437.USD"],"gpt_icon":0},{"id":"2603574757","title":"Abbisko Tumor Treatment Pimicotinib Accepted for U.S. Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2603574757","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603574757?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:47","pubTimestamp":1768279662,"startTime":"0","endTime":"0","summary":"Abbisko  said its tumor treatment pimicotinib was accepted for review in the U.S., according to a Hong Kong bourse filing Tuesday.The drug, which is also known as ABSK021, is meant to treat patients with tenosynovial giant cell tumor.Pimicotinib is licensed to Germany's Merck KGaA for worldwide commercialization.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU2476274720.SGD","LU2476274308.USD","LU2488822045.USD","IE00BPRC5H50.USD","02256","LU2778985437.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"1172213515","title":"ABBISKO-B (02256) Announces FDA Acceptance of Bejema® NDA for TGCT Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1172213515","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172213515?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:25","pubTimestamp":1768278354,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced on January 13, 2026, that its subsidiary, Shanghai Abbisko Biopharmaceuticals (Abbisko), declared that the New Drug Application (NDA) for its self-developed, novel, oral,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","IE00B543WZ88.USD","BK1161","IE00B5MMRT66.SGD","LU2476274720.SGD","IE00BPRC5H50.USD","LU2778985437.USD","02256","LU2476274308.USD"],"gpt_icon":0},{"id":"2603571793","title":"Abbisko Cayman - Unit's New Drug Application for Colony-Stimulating Factor 1 Receptor Inhibitor Pimicotinib Formally Accepted by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603571793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603571793?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:07","pubTimestamp":1768277270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02256","IE00BPRC5H50.USD","LU2476274720.SGD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1161"],"gpt_icon":0},{"id":"2603717975","title":"Abbisko Therapeutics Secures FDA Acceptance for Pimicotinib NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603717975","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603717975?lang=en_us&edition=fundamental","pubTime":"2026-01-13 12:07","pubTimestamp":1768277228,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics, Subsidiary of Abbisko Cayman Ltd., Announces FDA Acceptance of Pimicotinib NDA for TGCT Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Cayman Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL441P1h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU2488822045.USD","BK1161","LU2476274720.SGD","IE00B543WZ88.USD","LU2476274308.USD","IE00B5MMRT66.SGD","02256","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"1173645093","title":"Major Breakthrough: Abbisko-B's (02256) Tenosynovial Giant Cell Tumor Drug Bejema® NDA Accepted by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1173645093","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173645093?lang=en_us&edition=fundamental","pubTime":"2026-01-13 09:30","pubTimestamp":1768267837,"startTime":"0","endTime":"0","summary":"On January 13, 2026, Abbisko-B (02256) announced that the New Drug Application (NDA) for its self-developed, novel, oral, highly selective, and potent small molecule Colony-Stimulating Factor 1...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00B543WZ88.USD","BK1574","LU2476274308.USD","LU2778985437.USD","02256","BK1161","159938","IE00B5MMRT66.SGD","LU2488822045.USD","09939","LU2476274720.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2603520653","title":"FDA Accepts Abbisko Cayman NDA for Pimicotinib in Tenosynovial Giant Cell Tumor","url":"https://stock-news.laohu8.com/highlight/detail?id=2603520653","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603520653?lang=en_us&edition=fundamental","pubTime":"2026-01-13 08:54","pubTimestamp":1768265682,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics Co., Ltd.  announced that the U.S. Food and Drug Administration  has formally accepted the New Drug Application  for pimicotinib  for the systemic treatment of patients with tenosynovial giant cell tumor . Pimicotinib, an orally administered, highly selective colony-stimulating factor 1 receptor  inhibitor, was developed by Abbisko Therapeutics and is licensed to Merck KGaA, Darmstadt, Germany, for worldwide commercialization. The NDA acceptance is supported by data from the Phase III MANEUVER trial, which demonstrated statistically significant improvements in objective response rate and patient-reported outcomes. Pimicotinib was previously approved in China by the National Medical Products Administration  for adult patients with symptomatic TGCT. Regulatory submissions for pimicotinib are also under review in other markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLtGq4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274308.USD","02256","IE00B543WZ88.USD","BK1161","IE00BPRC5H50.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":89,"code":"91000000","status":"200"}]}}